The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Covidien to Present at Leerink Swann Conference

Thursday, February 09, 2012

Covidien to Present at Leerink Swann Conference07:00 EST Thursday, February 09, 2012 MANSFIELD, Mass. (Business Wire) -- Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Leerink Swann 2012 Global Healthcare Conference in New York, New York, on February 16, 2012. Charles J. Dockendorff, Executive Vice President and Chief Financial Officer, will discuss the Company in a presentation scheduled to begin at 8:30AM ET. A live audio webcast of the presentation can be accessed at Covidien's Investor Relations website: http://investor.covidien.com. About Covidien Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. CovidienEric Kraus, 508-261-8305Senior Vice PresidentCorporate Communicationseric.kraus@covidien.comorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor Relationscole.lannum@covidien.comorBruce Farmer, 508-452-4372Vice PresidentPublic Relationsbruce.farmer@covidien.comorTodd Carpenter, 508-452-4363DirectorInvestor Relationstodd.carpenter@covidien.com